It has been reported that AMPK/Nrf2 signaling pathway plays a critical role against oxidative stress and proinflammatory responses to reverse metabolic disorders in DN [54] and nonalcoholic fatty liver disease [31]. Here, PRKAA2 is linked to metabolic dysfunction-associated steatotic liver disease.